ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 10 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,000 | -26.7% | 21,300 | 0.0% | 0.00% | – |
| Q4 2015 | $15,000 | -28.6% | 21,300 | 0.0% | 0.00% | – |
| Q3 2015 | $21,000 | -19.2% | 21,300 | 0.0% | 0.00% | – |
| Q2 2015 | $26,000 | +13.0% | 21,300 | 0.0% | 0.00% | – |
| Q1 2015 | $23,000 | -4.2% | 21,300 | 0.0% | 0.00% | – |
| Q4 2014 | $24,000 | 0.0% | 21,300 | 0.0% | 0.00% | – |
| Q3 2014 | $24,000 | +4.3% | 21,300 | 0.0% | 0.00% | – |
| Q2 2014 | $23,000 | -72.0% | 21,300 | -73.1% | 0.00% | – |
| Q1 2014 | $82,000 | -10.9% | 79,300 | 0.0% | 0.00% | – |
| Q4 2013 | $92,000 | -83.5% | 79,300 | -75.1% | 0.00% | -100.0% |
| Q3 2013 | $557,000 | -28.5% | 318,220 | -22.3% | 0.00% | -50.0% |
| Q2 2013 | $779,000 | – | 409,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ancora Advisors LLC | 50,000 | $20,000 | 0.00% |
| MONARCH CAPITAL MANAGEMENT INC/ | 10,000 | $4,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 122,287 | $50,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 254,200 | $103,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 47,998 | $19,000 | 0.00% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 11,181 | $5,000 | 0.00% |
| Kistler-Tiffany Companies, LLC | 825 | $0 | 0.00% |
| Tradewinds Capital Management, LLC | 200 | $0 | 0.00% |
| NEXT Financial Group, Inc | 60 | $0 | 0.00% |
| CT Financial Advisors LLC | 2,000 | $810,000 | 0.00% |